Drug Profile
AB 301
Alternative Names: AB-301; Pegylated human glucagon-like peptide-1 agonist/AB 101Latest Information Update: 28 Oct 2019
Price :
$50
*
At a glance
- Originator AntriaBio
- Developer Rezolute
- Class Antihyperglycaemics; Insulins; Pancreatic hormones
- Mechanism of Action Glucagon like peptide 1 receptor agonists; Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Type 2 diabetes mellitus